Therefore, the upregulation of SLC1A5 inhibits the production of MDA and upregulates GPX4 to reduce oxidative stress-related damage, thereby accelerating cell proliferation and promoting malignant tumor progression. The gene discussed is GPX4; the disease is cancer.